Pfizer Inc. reports that its revenue in the first quarter of 2021 amounted to $14.6 billion, soaring 45% compared to the same period a year earlier. That's an increase of roughly $4.6 billion.

Reported earnings per share (EPS) climbed 44% year on year to $0.86 and adjusted EPS stood at $0.93. Reported net income was $4.9 billion, while adjusted net income came in at $5.3 billion. That's additional profits of roughly $1.7 billion. Pfizer also noted it raised its revenues and EPS guidance for 2021.

"I am extremely proud of the way we have begun 2021, delivering strong financial results in the first quarter. Even excluding the growth provided from BNT162b2 [COVID-19 vaccine], our revenues grew 8% operationally, which aligns with our stated goal of delivering at least a 6% compound annual growth rate through 2025," CEO Albert Bourla stated.

Meanwhile, NBC just said the Biden Administration is spending $3 billion on vaccine hesitancy "education" and to combat vaccine "disinformation."

And just a reminder, former FDA commissioner and hyper-promoter of COVID vaccines, Scott Gottlieb, sits on the board of Pfizer and promotes the COVID vaccination of children.